Aljuffali, I.A.; Anwer, M.K.; Ahmed, M.M.; Alalaiwe, A.; Aldawsari, M.F.; Fatima, F.; Jamil, S.
Development of Gefitinib-Loaded Solid Lipid Nanoparticles for the Treatment of Breast Cancer: Physicochemical Evaluation, Stability, and Anticancer Activity in Breast Cancer (MCF-7) Cells. Pharmaceuticals 2023, 16, 1549.
https://doi.org/10.3390/ph16111549
AMA Style
Aljuffali IA, Anwer MK, Ahmed MM, Alalaiwe A, Aldawsari MF, Fatima F, Jamil S.
Development of Gefitinib-Loaded Solid Lipid Nanoparticles for the Treatment of Breast Cancer: Physicochemical Evaluation, Stability, and Anticancer Activity in Breast Cancer (MCF-7) Cells. Pharmaceuticals. 2023; 16(11):1549.
https://doi.org/10.3390/ph16111549
Chicago/Turabian Style
Aljuffali, Ibrahim A., Md. Khalid Anwer, Mohammed Muqtader Ahmed, Ahmed Alalaiwe, Mohammed F. Aldawsari, Farhat Fatima, and Shahid Jamil.
2023. "Development of Gefitinib-Loaded Solid Lipid Nanoparticles for the Treatment of Breast Cancer: Physicochemical Evaluation, Stability, and Anticancer Activity in Breast Cancer (MCF-7) Cells" Pharmaceuticals 16, no. 11: 1549.
https://doi.org/10.3390/ph16111549
APA Style
Aljuffali, I. A., Anwer, M. K., Ahmed, M. M., Alalaiwe, A., Aldawsari, M. F., Fatima, F., & Jamil, S.
(2023). Development of Gefitinib-Loaded Solid Lipid Nanoparticles for the Treatment of Breast Cancer: Physicochemical Evaluation, Stability, and Anticancer Activity in Breast Cancer (MCF-7) Cells. Pharmaceuticals, 16(11), 1549.
https://doi.org/10.3390/ph16111549